Search

Your search keyword '"ZHANG Ya-Jing"' showing total 315 results

Search Constraints

Start Over You searched for: Author "ZHANG Ya-Jing" Remove constraint Author: "ZHANG Ya-Jing"
315 results on '"ZHANG Ya-Jing"'

Search Results

1. Progress in diagnosis and treatment of dermatomyositis

6. Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence

8. Unextendible maximally entangled bases and mutually unbiased bases in multipartite systems

12. Combined Mindfulness‐Based Stress Reduction and Exercise Intervention for Improving Psychological Well‐Being in Patients With Non‐Small Cell Lung Cancer.

15. Zircon U-Pb and molybdenite Re-Os dating and geological implications of the Shimadong porphyry molybdenum deposit in eastern Yanbian, northeastern China

18. Supplementary Appendix from Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial

19. Supplementary figure 2 from Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial

20. Supplementary figure 6 from Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial

21. Supplementary figure 1 from Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial

22. Supplementary figure 5 from Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial

23. Data from Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial

24. Supplementary figure 3 from Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial

25. Supplementary tables from Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial

26. Supplementary figure 4 from Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial

28. Deactivation mechanism of Cu/SiO2catalyst in gas phase hydrogenation of furfural to furfuryl alcohol

36. Warm acupuncture therapy alleviates neuronal apoptosis after spinal cord injury via inhibition of the ERK signaling pathway

40. Triassic igneous activities in the east flank of the East Kunlun orogenic belt: the Daheba complex example.

43. Novel Recombinant Human Thyroid-stimulating Hormone in Aiding Post-operative Assessment of Patients With Differentiated Thyroid Cancer--Phase I/II Study

Catalog

Books, media, physical & digital resources